Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1434, 2004-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Lifestyle modification best option for preventing type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. :
Access to resources
Recommend
Exenatide effective adjuvant to thiazolidinedione therapy for T2DM
Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. :
Exenatide an excellent option for T2DM
Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. :
Pioglitazone economically attractive for type 2 DM in Canada
Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. :
Pioglitazone economically attractive for type 2 DM in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 356, 2002-01 ,pp. :